Millions of Americans struggle with obesity.
In fact, we are inching closer to the 50/50 line—where nearly half of all U.S. adults are plagued with it.
Perhaps this is why the new “weight-loss wonder drugs,” like Ozempic, are taking the world by storm. After all, we’re seeing countless prescriptions for these medications.
But perhaps best of all are the “side effects” we never saw coming.
See, semaglutide (the ingredient marketed under brand names like Ozempic and Wegovy) is designed to treat Type 2 diabetes.
But the unintended side effects, like weight loss, are really turning heads.
What else can semaglutide do?
Vast protection to your heart
These GLP-1 agonist drugs are revolutionary—and only time will tell how they’ll impact our health in the long run.
But given the massive attention to semaglutide, researchers are already exploring how it might benefit other areas of health.
In addition to helping diabetics maintain blood sugar control—and sometimes aiding in weight loss—clinical evidence suggests semaglutide might also have a positive influence on your heart and brain.
In one study, researchers analyzed data from over 4,250 overweight or obese patients with heart failure. Ultimately, they found that semaglutide helped prevent major adverse cardiovascular events, like a heart attack or stroke.
They also noted a near-25 percent lower risk of cardiovascular disease-related deaths—and a 19 percent reduction in all-cause mortality, among semaglutide users.
And that’s not all…
A mood-booster?
Another study discovered that among thousands of patients using semaglutide, none of them were at an increased risk for developing conditions like depression or anxiety.
Researchers also linked the drug to a decreased risk of dementia!
(Learn more about the research behind Ozempic for neurodegenerative disorders, like Alzheimer’s and Parkinson’s, by clicking here.)
In fact, clinical evidence suggests semaglutide showcases neurobiological activity. Meaning it can help stave off inflammation and neuronal degeneration.
That’s a huge finding!
And tomorrow, we’ll take a closer look at how semaglutide measures up against certain neurological or psychological conditions. So, be sure to keep an eye on your inbox!
Sources:
“Semaglutide Reduces Risk Of Harmful Cardiovascular Events And Death In People With Heart Failure, New Study Suggests.” Forbes, 08/22/2024. (forbes.com/sites/ariannajohnson/2024/08/22/semaglutide-reduces-risk-of-harmful-cardiovascular-events-and-death-in-people-with-heart-failure-new-study-suggests/)
“Semaglutide linked to lower cognitive decline risk and reduced nicotine cravings.” Medical News Today, 07/19/2024. (medicalnewstoday.com/articles/semaglutide-linked-to-lower-cognitive-decline-risk-and-reduced-nicotine-cravings)